New clip device aims to fix leaky heart valve without open surgery
NCT ID NCT07509658
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is checking how well the TriClip device works and how safe it is for people in Japan with a leaky tricuspid valve. The device is already approved for use, and this study will follow 250 patients to confirm its benefits in everyday medical practice. The main goal is to see if the valve leakage is reduced to moderate or less within 30 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
TriClip System (a device that clips the tricuspid valve to reduce leakage)
What this could lead to
If successful, this study could confirm that the TriClip device works safely in Japanese patients, offering a less invasive treatment option for tricuspid regurgitation.
What could go wrong
This is an observational study, not a randomized trial, so results may be less definitive. The device is already approved, but long-term benefits and risks in this population are still being confirmed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
National Cerebral & Cardiovascular Center Hospital
RECRUITINGSuita, Osaka, 564-8565, Japan
Contact